Showing 1 - 1 results of 1 for search 'Bei-Fang Yang', query time: 0.01s Refine Results
  1. 1
    Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial

    Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults... by Bei-Fang Yang, Jing Jin, Xi-Ran He, Zhong-Hua Yang, Xiao’ai Qian, Ye-Qing Tong, Chang-Xian Ke, Zhao-Hong Li, Zhao-Xia Li, Lin-Feng Zhong, Ze-Hong Gan, Xian-Feng Zhang, Ying Zeng

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: